Aventis Launches New Antibiotic
INNOVATIVE KETOLIDE ANTIBIOTIC TO COMBAT COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS (CARTIs)
04-Feb-2002 -
Frankfurt, Germany, February 1, 2002 - Ketek® (telithromycin), the world's first ketolide antibiotic to reach the market, was recently launched in two additional European countries, Spain and Italy. This follows the very successful initial launch of Ketek in Germany last October. Ketek achieved ...
antibiotics
Aventis
bacteria
+8